Gilead says remdesivir helped moderate COVID-19 patients improve

Reuters

01 Jun 2020 0 shares 1 views

Gilead says remdesivir helped moderate COVID-19 patients improve

Reuters

Published 01 Jun 2020

Gilead Sciences Inc said on Monday results from a study showed its antiviral drug remdesivir demonstrated significantly greater clinical improvement in patients with moderate COVID-19.

Full Article

Gilead to enroll pediatric patients for late-stage remdesivir study

Reuters 17 Jun 2020

Drugmaker Gilead Sciences said on Wednesday it will soon begin enrollment of pediatric patients with moderate-to-severe COVID-19 in..

Israel approves remdesivir drug for COVID-19 treatment
Reuters 16 Jun 2020
Singapore approves remdesivir drug for emergency COVID-19 treatment
Reuters 10 Jun 2020
Singapore approves Gilead's remdesivir for COVID-19 treatment
Reuters 10 Jun 2020
India approves Gilead's remdesivir to treat severe COVID-19 cases
Reuters 03 Jun 2020

More coverage

Gilead's next step on coronavirus: inhaled remdesivir, other easier-to-use versions
Reuters 02 Jun 2020
India approves emergency use of remdesivir to treat COVID-19 patients
Reuters 02 Jun 2020

Gilead's remdesivir shows modest improvement in moderate COVID-19 patients
Reuters 01 Jun 2020
Gilead remdesivir results mixed in moderate COVID-19 patients
Reuters 01 Jun 2020

Gilead says remdesivir helped moderate COVID-19 patients improve

Gilead says remdesivir helped moderate COVID-19 patients improve

You might like

Related news coverage

Gilead to enroll pediatric patients for late-stage remdesivir study

Advertisement

More coverage